HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MK-2640

a glucose-responsivei nsulin–oligosaccharide conjugate

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Peptide Hormones: 1347
    - Pancreatic Hormones: 113
      - Insulins: 644
        Proinsulin: 1195
        Insulin: 113363
        MK-2640: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Peptide Hormones: 1347
    - Pancreatic Hormones: 113
      - Insulins: 644
        Proinsulin: 1195
        Insulin: 113363
        MK-2640: 1

Experts

1.	Bernstein, Harold S: 1 article (01/2019)
2.	Crutchlow, Michael: 1 article (01/2019)
3.	Fancourt, Craig: 1 article (01/2019)
4.	Iwamoto, Marian: 1 article (01/2019)
5.	Kaarsholm, Niels C: 1 article (01/2019)
6.	Kandala, Bhargava: 1 article (01/2019)
7.	Kelley, David E: 1 article (01/2019)
8.	Krug, Alexander W: 1 article (01/2019)
9.	Morrow, Linda: 1 article (01/2019)
10.	Stoch, S Aubrey: 1 article (01/2019)

Related Diseases

1.	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/01/2019 - "In a randomized, 2-period crossover trial in 16 subjects with type 1 diabetes mellitus to evaluate glucose-responsiveness of i.v. administered MK-2640, we were unable to demonstrate a glucose-dependent change in MK-2640 clearance, although a significant glucose-dependent augmentation of glucose infusion rate was observed. "

Related Drugs and Biologics

1.	Glucose (Dextrose)